C-terminally shortened pituitary adenylate cyclase-activating peptides (PACAP) discriminate PACAP I, PACAP II-VIP1 and PACAP II-VIP2 recombinant receptors

Regulatory Peptides

Volumn 62, Issue 2-3, 1996, Pages 125-130

  Gourlet, Philippe ^a   Vandermeers, André ^a   Vandermeers Piret, Marie Claire ^a   Rathé, Jean ^a   De Neef, Philippe ^a   Robberecht, Patrick ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

PACAP analogue; PACAP, Type I receptor, Type II receptor

Indexed keywords

ADENYLATE CYCLASE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE 27; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE DERIVATIVE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

ANIMAL CELL; ARTICLE; DRUG POTENCY; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; HAMSTER; NONHUMAN; OVARY CELL; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR OCCUPANCY;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS;

EID: 0029951401     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/0167-0115(96)00010-9     Document Type: Article

References (30)

1. Christophe, J., Type 1 receptors for PACAP (a neuropeptide even more important than VIP?), Biochim. Biophys. Acta, 1154 (1993) 183-199.
2. Robberecht, P., Cauvin, A., Gourlet, P. and Christophe, J., Heterogeneity of VIP receptors. In R. Pauwels, R.A. Lefebvre and A.G. Herman (Eds.), Second Workshop on Nonadrenergic Noncholinergic Mechanisms, Arch. Int. Pharmacodyn. Ther., Vol. 303, 1990, pp. 51-66.
3. Ishihara, T., Shigemoto, R., Mori, K., Takahashi, K. and Nagata, S., Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide, Neuron, 8 (1992) 811-819.
4. 2 receptor: molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide, FEBS Lett., 334 (1993) 3-8.
5. Svoboda, M., Tastenoy, M., Van Rampelbergh, J., Goossens, J.-F., De Neef, P., Waelbroeck, M. and Robberecht, P., Molecular cloning and functional characterization of a human VIP receptor from SUP-T1 lymphoblasts, Biochem. Biophys. Res. Commun., 205 (1994) 1617-1624.
6. Pisegna, J.R. and Wank, S.A., Molecular cloning and functional expression of the pituitary adenylate cyclase-activating polypeptide type I receptor, Proc. Natl. Acad. Sci. USA, 90 (1993) 6345-6349.
7. Svoboda, M., Tastenoy, M., Ciccarelli, E., Stiévenart, M. and Christophe, J., Cloning of a splice variant of the pituitary adenylate cyclase-activating polypeptide (PACAP) type I receptor, Biochem. Biophys. Res. Commun., 195 (1993) 881-888.
8. Spengler, D., Waeber, C., Pantaloni, C., Holsboer, F., Bockaert, J., Seeburg, P.H. and Journot, L., Differential signal transduction by five splice variants of the PACAP receptor, Nature, 365 (1993) 170-175.
9. Ciccarelli, E., Svoboda, M., De Neef, P., Di Paolo, E., Bollen, A., Dubeaux, C., Vilardaga, J.-P., Waelbroeck, M. and Robberecht, P., Pharmacological properties of two recombinant splice variants of the PACAP type I receptor transfected and stably expressed in CHO cells, Eur. J. Pharmacol., 288 (1995) 259-267.
10. Ciccarelli, E., Vilardaga, J.-P., De Neef, P., Di Paolo, E., Waelbroeck, M., Bollen, A. and Robberecht, P., Properties of the VIP-PACAP type II receptor stably expressed in CHO cells, Regul. Pept., 54 (1994) 397-407.
11. Vertongen, P., D'Haens, J., Michotte, A., Velkeniers, B., Van Rampelbergh, J., Svoboda, M. and P. Robberecht, P., Expression of Pituitary Adenylate Cyclase Activating Polypeptide and receptors in human brain tumors, Peptides, 16 (1995) 713-719.
12. Vertongen, P., Ciccarelli, E., Woussen-Colle, M.-C., De Neef, P., Robberecht, P. and Cauvin, A., Pituitary adenylate cyclase-activating polypeptide receptors of types I and II and glucagon-like peptide-I receptors are expressed in the rat medullary carcinoma of the thyroid cell line 6/23, Endocrinology, 135 (1994) 1537-1542.
13. Robberecht, P., Waelbroeck, M., De Neef, P., Tastenoy, M., Gourlet, P., Cogniaux, J. and Christophe, J., A new type of functional VIP receptor has an affinity for helodermin in human SUP-T1 lymphoblasts, FEBS Lett., 228 (1988) 351-355.
14. Robberecht, P., Waelbroeck, M., Dehaye, J.P., Winand, J., Vandermeers, A., Vandermeers-Piret, M.C. and Christophe, J., Evidence that Helodermin, a newly extracted peptide from Gila monster venom, is a member of the secretin/VIP/PHI family of peptides with an original pattern of biological properties, FEBS Lett., 166 (1984) 277-282.
15. Gourlet, P., Vandermeers, A., Vandermeers-Piret, M.-C., Rathé, J., De Neef, P. and P. Robberecht, P., Fragments of pituitary adenylate cyclase activating polypeptide discriminate between type I and II recombinant receptors, Eur. J. Pharmacol., 287 (1995) 7-11.
16. Salomon, Y., Londos, C. and Rodbell, M., A highly sensitive adenylate cyclase assay, Anal. Biochem., 58 (1974) 541-548.
17. Ambrosius, D., Casaretto, M., Gerardy-Schahn, R., Saunders, D., Brandenburg, D. and Zahn, H., Peptide analogues of the anaphylatoxin C3a; syntheses and properties, Biol. Chem. Hoppe-Seyler, 370 (1989) 217-227.
18. Robberecht, P., Gourlet P., De Neef, P., Woussen-Colle, M.-C., Vandermeers-Piret, M.-C., Vandermeers, A. and Christophe, J., Structural requirements for the occupancy of PACAP (Pituitary Adenylate Cyclase Activating Peptide) receptors and adenylate cyclase activation in human neuroblastoma NB-OK-1 cell membranes: discovery of PACAP(6-38) as a potent antagonist, Eur. J. Biochem., 207 (1992) 239-246.
19. Vilardaga, J.P., Ciccarelli, E., Dubeaux, C., De Neef, P., Bollen, A. and Robberecht, P., Properties and regulation of the coupling to adenylate cyclase of the secretin receptor stably transfected in CHO cells, Mol. Pharmacol., 45 (1994) 1022-1028.
20. Couvineau, A., Rouyer-Fessard, C., Fournier, A., St-Pierre, S. Pipkorn, R. and Laburthe, M., Structural requirements for VIP interaction with specific receptors in human and rat intestinal membranes: effect of nine partial sequences, Biochem. Biophys. Res. Commun., 121 (1984) 493-498.
21. Frandsen, E.K., Grønvald, F.C., Heding L.G., Johansen, N.L., Lundt, B.T., Moody, A.J., Markussen, J. and Vølund, A., Glucagon: structure-function relationships investigated by sequence deletions, Hoppe Seyler's Z. Physiol. Chem., 362 (1981) S.665-677.
22. Goossens, J.-F., Pommery, N., Lohez, M., Pommery, J., Helbecque, N., Cotelle, P., Lhermitte, M. and Henichart, J.P., Antagonistic effect of vasoactive intestinal peptide fragment, vasoactive intestinal peptide(1-11), on guinea pig trachea smooth muscle relaxation, Mol. Pharmacol., 41 (1992) 104-109.
23. O'Donnell, M., Garippa, R.J., O'Neill, N.C., Bolin, D.R. and Cottrell, J.M., Structure-activity studies of vasoactive intestinal polypeptide, J. Biol. Chem., 266 (1991) 6389-6392.
24. Schäfer, H. and Schmidt, W.E., Characterization and purification of the solubilized pituitary adenylate-cyclase-activating polypeptide-1 receptor from porcine brain using a biotinylated ligand, Eur. J. Biochem., 217 (1993) 823-830.
25. Schäfer, H., Schwarzhoff, R., Creutzfeldt, W. and Schmidt, W.E., Characterization of a guanosine-nucleotide-binding-protein-coupled receptor for pituitary adenylate-cyclase-activating polypeptide on plasma membranes from rat brain, Eur. J. Biochem., 202 (1991) 951-958.
26. Schmidt, W.E., Höcker, M., Katsoulis, S., Gallwitz, B., Stüber, E., Schwarzhoff, R., Schäfer, H., Eckart, K., Fölsch, U.R. and Creutzfeldt, W., PACAP-27 and PACAP-38 - Synthesis and biological activity of two novel regulatory brain-gut peptides, Digestion, 46 (1990) S1, 101.
27. Kenakin, T., Agonist-receptor efficacy I: mechanisms of efficacy and receptor promiscuity, Trends Pharmacol. Sci., 16 (1995) 188-192.
28. ] Kenakin, T., Agonist-receptor efficacy II: agonist trafficking of receptor signals, Trends Pharmacol. Sci., 16 (1995) 232-238.
29. Inooka, H., Endo, S., Kitada, C., Mizuta, E. and Fujino, M., Pituitary adenylate cyclase activating polypeptide (PACAP) with 27 residues, Int. J. Peptide Protein Res., 40 (1992) 456-464.
30. Wray, V., Kakoschke, C., Nokihara, K. and Naruse, S., Solution structure of pituitary adenylate cyclase activating polypeptide by nuclear magnetic resonance spectroscopy, Biochemistry, 32 (1993) 5832-5841.